- Joined
- Jul 17, 2012
- Messages
- 95
- Reaction score
- 0
"Naproxen, a nonsteroidal anti-inflammatory drug that is the active ingredient in Aleve, has a specific rotation of +66. One commercial preparation results in a mixture that has a 97% enantiomeric excess."
Question: What percent of each enantiomer is obtained from the commercial preparation?
I know you just do 97% + (3%/2) = 98.5% of one enantiomer and then 100% - 98.5% = 1.5% of the enantiomer, but my book says the following:
"97% of the commercial preparation is (+)-naproxen; 3% is a racemic mixture. Therefore the commercial preparation forms 98.5% (+)-naproxen and 1.5% (-)-naproxen."
How do we know which percentage is for (+)-naproxen versus (-)-naproxen? I don't know why it's saying that 97% of the preparation was (+)-naproxen. Where did that come from? All we know is that there's 97% enantiomeric excess, but it didn't say which enantiomer there was an excess of. Am I missing something?
Question: What percent of each enantiomer is obtained from the commercial preparation?
I know you just do 97% + (3%/2) = 98.5% of one enantiomer and then 100% - 98.5% = 1.5% of the enantiomer, but my book says the following:
"97% of the commercial preparation is (+)-naproxen; 3% is a racemic mixture. Therefore the commercial preparation forms 98.5% (+)-naproxen and 1.5% (-)-naproxen."
How do we know which percentage is for (+)-naproxen versus (-)-naproxen? I don't know why it's saying that 97% of the preparation was (+)-naproxen. Where did that come from? All we know is that there's 97% enantiomeric excess, but it didn't say which enantiomer there was an excess of. Am I missing something?
Last edited: